Browsing by Author "Kalayoglu, Munci"
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
Item Liver Transplant in a Patient with Active Pulmonary Tuberculosis(Başkent Üniversitesi, 2010-09) Yankol, Yucel; Kalayoglu, Munci; Acarli, Koray; Alan, Servet; Kanmaz, Turan; Kocak, Burak; Topaloglu, SerdarObjectives: Immunosuppressive treatment generally increases the severity of active infection. Therefore, liver transplant is contraindicated in the presence of active tuberculosis. Despite the importance of supportive treatment, liver transplant is the only treatment for fulminant hepatic failure. Materials and Methods: We report a case of successful liver transplant for fulminant hepatic failure in the presence of active tuberculosis infection. Results: We immediately performed a liver transplant from a live donor. The patient received low-dose immunosuppressive treatment and antituberculosis treatment. The patient was cured and discharged on the 25th day after surgery. We stopped antituberculosis treatment 10 months after discharge. The patient has been followed for 32 months after transplant with normal graft function and has been free of pulmonary tuberculosis infection. Conclusions: Liver transplant can be performed in cirrhotic patients with active infections, such as tuberculosis, as a life-saving procedure.Item Liver Transplantation for Biliary Atresia: 19-Year, Single-Center Experience(Başkent Üniversitesi, 2004-06) Chin, L Thomas; D’Alessandro, Anthony M; Knechtle, Stuart J; Fernandez, Luis A; Leverson, Glen; Judd, Robert H; Spaith, Elizabeth; Dalgic, Aydin; Sollinger, Hans W; Kalayoglu, MunciIn this study, we describe our 19-year experience with liver transplantation as the definitive treatment for congenital biliary atresia. Materials and Methods: We performed a retrospective study of 115 liver transplants from 1984 to 2003 in 85 patients with congenital biliary atresia. We determined the impact of era of transplantation (1984-1993 and 1994-2003), recipient age (< 1 and > 1), prior portoenterostomy, and type of surgery (whole-, reduced-, and split-liver transplant) on the outcome of the transplant. Results: Overall long-term survival is 83%. Survival is greater in the more-recent era. No impact of age or prior portoenterostomy on survival was seen. Split- liver grafts showed superior graft survival, whereas reduced-liver transplants had the worst overall graft survival. Conclusions: Our results confirm that long-term patient survival after liver transplantation for congenital biliary atresia is excellent. When required, partial liver grafts provide excellent long-term outcome.Item Successful ABO-Incompatible Liver Transplantation with Pre- and Postoperative Plasmapheresis, Triple Immunosuppression, and Splenectomy for Fulminant Hepatic Failure(Başkent Üniversitesi, 2005-12) Yagci, Gokhan; Cetiner, Sadettin; Yigitler, Cengizhan; Sonmez, Alper; Mas, M. Refik; Cosar, Ahmet; Dalgic, Aydin; Kalayoglu, MunciFulminant hepatic failure continues to be a challenge to hepatologists and surgeons. Because of the rapid deterioration in the clinical condition of patients with fulminant hepatic failure and the scarcity of available grafts, an ABO-incompatible liver donor may be the only choice for a patient with life-threatening hepatic insufficiency. Here, we report a patient with fulminant hepatic failure who received an ABO-incompatible liver transplantation who was treated with pre- and posttransplantation double-volume total plasma exchange, splenectomy, and triple immunosuppression (tacrolimus, mycophenolate mofetil, and prednisone) in July 2003. At 26 months’ follow-up, the patient’s postoperative course has been uneventful. Using protocols aimed at removing existing isohemagglutinins and reducing further antibody production, ABO-incompatible liver transplantation may be performed as a life-saving procedure in patients with fulminant hepatic failure.